Latest FDA Stories
Integrated System Streamlines Diabetes Management for Patients CHESTERBROOK, Pa., Dec.
IGI Now Has Nineteen Applications Pending at the FDA BUENA, N.J., Dec. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
Accurate Norovirus Detection in as Little as One Hour SUNNYVALE, Calif., Dec. 1, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S.
An independent compliance audit found that SureClinical eTMF Cloud meets or exceeds European Commission and FDA regulatory requirements. Rancho Cordova, CA (PRWEB)
On November 24, the US FDA notified consumers not to purchase or use Super Extreme Accelerator because it contains undeclared drug ingredient.
On November 24, the US FDA notified consumers not to purchase or use Bee Slim due to undeclared drug ingredient.
CORK, Ireland, November 27, 2014 /PRNewswire/ -- Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S.
On November 20, Evershing International Trading announced the recall of Vinacafe Brand Coffee Wake Up Weasel Instant Coffee mix 3‐in‐1 due to allergy alert.
--Company Plans to Complete a New Human Factor Validation Study and Respond to the CRL in the First Half of Calendar 2015-- ALISO VIEJO, Calif., Nov.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.